While value-based purchasing can improve patient outcomes and reduce healthcare spending, low-value tests and screening plagues the industry, according to RevCycleIntellegence.
About 15 percent of healthcare providers admitted they were unsure what tests to give their patients, revealing that almost 21 percent of laboratory test were unnecessary for the patient, according to a 2014 study published in the American Journal of Clinical Pathology.
Decreasing these low-value services through collaboration between laboratory experts and clinicians could save hospitals billions of dollars, according to RevCycleIntelligence, which cited a 2009 study published in Health Affairs.
“Laboratory medicine experts are uniquely positioned to ensure this is achieved by working with physicians to devise optimal diagnostic and therapeutic protocols, leading to better health outcomes and reduced costs,” said AACC CEO Janet Kreizman.
More articles on healthcare finance:
Mercy Health Network, AmeriHealth dodge split, helping 220k residents on Medicaid
NYC Health + Hospitals sees operating loss nearly double to $673M
NY cancer center avoids Medicare reimbursement cut after $250k typo
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
